Joseph Chang
Geen lopende functies
Vermogen: 1 M $ op 30-04-2024
Profiel
Joseph Y.
Chang served as the Lead Independent Director at Optimer Pharmaceuticals LLC from 2012 to 2013.
Prior to that, he was the Vice President-Clinical Studies & Pharmacology at Pharmanex, Inc. from 1998 to 2006.
He also held the position of President & Chief Scientific Officer at Binary Therapeutics, Inc. from 1994 to 1997 and at Osteoarthritis Sciences, Inc. from 1991 to 1994.
Currently, he is the Chief Scientific Officer & EVP-Product Development at Nu Skin Enterprises, Inc. since 1997.
Dr. Chang obtained a doctorate degree from the University of London in 1978 and an undergraduate degree from the University of Portsmouth.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
08-04-2024 | 92 441 ( 0.19% ) | 1 M $ | 30-04-2024 |
Eerdere bekende functies van Joseph Chang
Bedrijven | Functie | Einde |
---|---|---|
NU SKIN ENTERPRISES, INC. | Hoofd Techniek/Wetenschap/O&O | 30-03-2024 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Directeur/Bestuurslid | 24-10-2013 |
Pharmanex, Inc.
Pharmanex, Inc. Food RetailRetail Trade Pharmanex, Inc. provided dietary supplement products. It offered anti aging with nutritional supplement products. The company was founded by William E. McGlashan Jr. and Michael N. Chang in 1994 and was headquartered in Provo, UT. | Corporate Officer/Principal | 01-02-2006 |
Binary Therapeutics, Inc. | President | 01-01-1997 |
Osteoarthritis Sciences, Inc. | President | 01-01-1994 |
Opleiding van Joseph Chang
University of Portsmouth | Undergraduate Degree |
University of London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NU SKIN ENTERPRISES, INC. | Consumer Non-Durables |
Bedrijven in privébezit | 4 |
---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Binary Therapeutics, Inc. | |
Pharmanex, Inc.
Pharmanex, Inc. Food RetailRetail Trade Pharmanex, Inc. provided dietary supplement products. It offered anti aging with nutritional supplement products. The company was founded by William E. McGlashan Jr. and Michael N. Chang in 1994 and was headquartered in Provo, UT. | Retail Trade |
Osteoarthritis Sciences, Inc. |